Package | us.nlm.vsac |
Type | ValueSet |
Id | Id |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1146.1600/expansion |
Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1600 |
Version | 20230602 |
Status | active |
Date | 2023-06-02T01:03:51-04:00 |
Name | HIVInfectionARVIntegraseStrandTransferInhibitorsINSTIsRXNORM |
Title | HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM) |
Experimental | False |
Realm | us |
Authority | hl7 |
Description | All prescribable medication formulations represented using either a "generic" or "brand-specific" concept. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), or SBD (semantic brand drug). GPCK (generic pack), BPCK (brand pack), SCDG (semantic clinical drug group), SBDG (semantic brand drug group), SCDF (semantic clinical drug form), IN (ingredient) or SBDF (semantic brand drug form) are NOT included in this value set. This value set does not include oral administration concepts, only concepts for medications administered specifically for overdose (injection, nasal). |
Purpose | (Clinical Focus: This set of values contains codes for prescribable medications for HIV),(Data Element Scope: Medications that were administered, ordered or prescribed.),(Inclusion Criteria: ARV Integrase Strand Transfer Inhibitors),(Exclusion Criteria: SBDG (semantic brand drug group), SCDF (semantic clinical drug form), or SBDF (semantic brand drug form).) |
No resources found
CodeSystem | |
http://www.nlm.nih.gov/research/umls/rxnorm ![]() | RxNorm |
http://www.nlm.nih.gov/research/umls/rxnorm ![]() | RxNorm |
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1146.1600",
"meta" : {
"versionId" : "13",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "CSTE Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-keyWord",
"valueString" : "HIV,Trigger"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-06-05"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2023-06-02"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1600",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1146.1600"
}
],
"version" : "20230602",
"name" : "HIVInfectionARVIntegraseStrandTransferInhibitorsINSTIsRXNORM",
"title" : "HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM)",
"status" : "active",
"date" : "2023-06-02T01:03:51-04:00",
"publisher" : "CSTE Steward",
"description" : "All prescribable medication formulations represented using either a \"generic\" or \"brand-specific\" concept. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), or SBD (semantic brand drug). GPCK (generic pack), BPCK (brand pack), SCDG (semantic clinical drug group), SBDG (semantic brand drug group), SCDF (semantic clinical drug form), IN (ingredient) or SBDF (semantic brand drug form) are NOT included in this value set. This value set does not include oral administration concepts, only concepts for medications administered specifically for overdose (injection, nasal).",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: This set of values contains codes for prescribable medications for HIV),(Data Element Scope: Medications that were administered, ordered or prescribed.),(Inclusion Criteria: ARV Integrase Strand Transfer Inhibitors),(Exclusion Criteria: SBDG (semantic brand drug group), SCDF (semantic clinical drug form), or SBDF (semantic brand drug form).)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "1235588",
"display" : "raltegravir 100 MG Chewable Tablet"
},
{
"code" : "1235591",
"display" : "raltegravir 100 MG Chewable Tablet [Isentress]"
},
{
"code" : "1235593",
"display" : "raltegravir 25 MG Chewable Tablet"
},
{
"code" : "1235595",
"display" : "raltegravir 25 MG Chewable Tablet [Isentress]"
},
{
"code" : "1433873",
"display" : "dolutegravir 50 MG Oral Tablet"
},
{
"code" : "1433879",
"display" : "dolutegravir 50 MG Oral Tablet [Tivicay]"
},
{
"code" : "1486838",
"display" : "raltegravir 100 MG Granules for Oral Suspension"
},
{
"code" : "1486841",
"display" : "raltegravir 100 MG Granules for Oral Suspension [Isentress]"
},
{
"code" : "1796077",
"display" : "dolutegravir 10 MG Oral Tablet"
},
{
"code" : "1796079",
"display" : "dolutegravir 10 MG Oral Tablet [Tivicay]"
},
{
"code" : "1796081",
"display" : "dolutegravir 25 MG Oral Tablet"
},
{
"code" : "1796083",
"display" : "dolutegravir 25 MG Oral Tablet [Tivicay]"
},
{
"code" : "1924313",
"display" : "raltegravir 600 MG Oral Tablet"
},
{
"code" : "1924315",
"display" : "raltegravir 600 MG Oral Tablet [Isentress]"
},
{
"code" : "2374562",
"display" : "dolutegravir 5 MG Tablet for Oral Suspension"
},
{
"code" : "2374566",
"display" : "dolutegravir 5 MG Tablet for Oral Suspension [Tivicay]"
},
{
"code" : "2475199",
"display" : "cabotegravir 30 MG Oral Tablet"
},
{
"code" : "2475205",
"display" : "cabotegravir 30 MG Oral Tablet [Vocabria]"
},
{
"code" : "2475410",
"display" : "cabotegravir 200 MG/ML Injectable Suspension"
},
{
"code" : "2588077",
"display" : "3 ML cabotegravir 200 MG/ML Injection"
},
{
"code" : "2588080",
"display" : "3 ML cabotegravir 200 MG/ML Injection [Apretude]"
},
{
"code" : "2594978",
"display" : "2 ML cabotegravir 200 MG/ML Injection"
},
{
"code" : "744842",
"display" : "raltegravir 400 MG Oral Tablet"
},
{
"code" : "744846",
"display" : "raltegravir 400 MG Oral Tablet [Isentress]"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:0568fdcb-f00b-475e-9dc8-6329bedfad50",
"timestamp" : "2024-12-10T06:36:31-05:00",
"total" : 23,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1235588",
"display" : "raltegravir 100 MG Chewable Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1235591",
"display" : "raltegravir 100 MG Chewable Tablet [Isentress]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1235593",
"display" : "raltegravir 25 MG Chewable Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1235595",
"display" : "raltegravir 25 MG Chewable Tablet [Isentress]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1433873",
"display" : "dolutegravir 50 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1433879",
"display" : "dolutegravir 50 MG Oral Tablet [Tivicay]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1486838",
"display" : "raltegravir 100 MG Granules for Oral Suspension"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1486841",
"display" : "raltegravir 100 MG Granules for Oral Suspension [Isentress]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1796077",
"display" : "dolutegravir 10 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1796079",
"display" : "dolutegravir 10 MG Oral Tablet [Tivicay]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1796081",
"display" : "dolutegravir 25 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1796083",
"display" : "dolutegravir 25 MG Oral Tablet [Tivicay]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1924313",
"display" : "raltegravir 600 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1924315",
"display" : "raltegravir 600 MG Oral Tablet [Isentress]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2374562",
"display" : "dolutegravir 5 MG Tablet for Oral Suspension"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2374566",
"display" : "dolutegravir 5 MG Tablet for Oral Suspension [Tivicay]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2475199",
"display" : "cabotegravir 30 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2475205",
"display" : "cabotegravir 30 MG Oral Tablet [Vocabria]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2588077",
"display" : "3 ML cabotegravir 200 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2588080",
"display" : "3 ML cabotegravir 200 MG/ML Injection [Apretude]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2594978",
"display" : "2 ML cabotegravir 200 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "744842",
"display" : "raltegravir 400 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "744846",
"display" : "raltegravir 400 MG Oral Tablet [Isentress]"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.